Efficacy and safety of cinepazide maleate injection in patients with acute ischemic stroke: a multicenter, randomized, double-blind, placebo-controlled trial

Abstract Background Ischemic stroke is a leading cause of morbidity and mortality. Thrombolytic therapy improves disability and survival rates; however, to be effective, it must be given within 4.5 h of onset. Moreover, thrombolytic therapy is frequently contraindicated. Therefore, alternative thera...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Jun Ni, Huisheng Chen, Guofang Chen, Yong Ji, Fei Yi, Zhuobo Zhang, Yi Yang, Jin Wu, Xueli Cai, Bei Shao, Jianfeng Wang, Yafang Liu, Deqin Geng, Xinhui Qu, Xiaohong Li, Yan Wei, Jianping Ding, Hua Lü, Yining Huang, Yonghua Huang, Bo Xiao, Tao Gong, Liying Cui, on behalf of the study collaboration group
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2020-07-01
سلاسل:	BMC Neurology
الموضوعات:	Acute cerebral infarction Cerebrovascular disease Cinepazide maleate Stroke
الوصول للمادة أونلاين:	http://link.springer.com/article/10.1186/s12883-020-01844-8
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!